Portfolio company
Amazentis
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotech company develops cellular nutrition products containing Urolithin A to improve mitochondrial health for consumers seeking healthy ageing and longevity.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Avea
This company manufactures longevity dietary supplements designed to support healthy ageing and cellular health for health-conscious consumers.
Elysium Health
This company develops and sells dietary supplements and biological age tests for consumers seeking to support cellular health and longevity.
Chrysea Labs
The company develops precision nutritional supplements and interventions designed to promote healthy ageing and manage chronic conditions for health-conscious consumers.
NOVOS
This company produces longevity supplements and biological age testing kits for health-conscious consumers seeking to slow the biological effects of ageing.
IMEL Biotherapeutics
This company develops mitochondrial replacement cell therapies for patients with genetic mitochondrial disorders and age-related diseases.
AminoSense
This company develops a biosensor platform for real-time amino acid measurement at home to help consumers optimize protein nutrition and metabolic health.
BioAge Labs
This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.
Endurance Bio
This biotechnology company develops oral small molecule therapeutics for patients with neurodegenerative and metabolic diseases to restore mitochondrial and lysosomal health.
